9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
AstraZeneca
OHSU Knight Cancer Institute
Incyte Corporation
DEKA Biosciences
Eli Lilly and Company
OHSU Knight Cancer Institute
City of Hope Medical Center
Rutgers, The State University of New Jersey